Fibromyalgia Trial, Recruiting NCT06879743 Sponsor: Cairo University Condition: Fibromyalgia
Back to Fibromyalgia

Fibromyalgia Trial, Recruiting

NCT06879743
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Women between 20 and 45 years old
  • People who have been diagnosed with fibromyalgia according to the 2016 American College of Rheumatology guidelines
  • People whose fibromyalgia symptoms have been present at a similar level for at least three months
  • People whose test results rule out other conditions that can cause similar symptoms, such as lupus, rheumatoid arthritis, and Lyme disease (this is checked through specific blood tests)

Who may not be able to join:

  • People who have another medical, neurological, or psychiatric illness
  • People who use strong opioid painkillers, or any painkillers other than paracetamol and/or ibuprofen
  • People who use benzodiazepines (a type of medication often used for anxiety or sleep)
  • People who use illicit drugs or alcohol
  • People who have recently used cannabis
  • People who are pregnant or breastfeeding
  • People who have other pain conditions besides fibromyalgia
  • People who have other autoimmune conditions, such as rheumatoid arthritis or lupus

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 01152322678

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 February 2024
Est. completion
1 April 2025

Where this trial is recruiting

🇪🇬 Egypt

Primary endpoints

Cortisol level

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov